亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Shen zheng Guangdong China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Payment Terms: CIF

    "1, Treatment and prevention of osteoporosis in postmenopausal women; 2, Treatment for ostealgia caused by metastatic bone cancer; 3, Treatment for the hypercalcemia caused by malignant neoplasm with or without metastatic bone cancers." "Highlights: 1, Decrease 30%~50% of the ratio and of skeletal related event (SRE), defer the occurrence time; 2, the 3rd generation of diphosphonate, more excellent penetrability makes it to be one of the most active diphosphonate; 3, Over 500,000 patients have been treated in more than 50 countries (Boniva® by Roche). 4, Time to market: 2012 5,Originator: Boniva® by Roche Registration Dossiers:non-clinical & clinical part, drug substance part and drug product part. "

Send your message to this supplier
  • From:
  • To:
    Shenzhen Mellowhope Pharm Industrial Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service